MENU

GANX Gain Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GANX is expected to report earnings to rise 7.82% to -18 cents per share on March 20

Gain Therapeutics GANX Stock Earnings Reports
Q4'24
Est.
$-0.18
Q3'24
Beat
by $0.04
Q2'24
Missed
by $0.23
Q1'24
Beat
by $0.09
Q4'23
Beat
by $0.04
The last earnings report on November 14 showed earnings per share of -17 cents, beating the estimate of -20 cents. With 193.24K shares outstanding, the current market capitalization sits at 41.64M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4800 Montgomery Lane
Phone
+1 301 500-1556
Employees
32
Web
https://www.gaintherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL248.05-5.43
-2.14%
Apple
SPY586.28-18.01
-2.98%
SPDR® S&P 500® ETF Trust
BTC.X100041.540000-6099.062500
-5.75%
Bitcoin cryptocurrency
TSLA440.13-39.73
-8.28%
Tesla
GME28.55-2.71
-8.67%
GameStop Corp

GANX and Stocks

Correlation & Price change

A.I.dvisor tells us that GANX and CRMD have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GANX and CRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GANX
1D Price
Change %
GANX100%
-8.33%
CRMD - GANX
29%
Poorly correlated
-4.92%
COYA - GANX
26%
Poorly correlated
-7.13%
OCUL - GANX
26%
Poorly correlated
-6.43%
VXRT - GANX
25%
Poorly correlated
-8.58%
OPT - GANX
25%
Poorly correlated
-3.22%
More